A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PEA / palmitoylethanolamide

[Related PubMed/MEDLINE]
Total Number of Papers: 445
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PEA  (>> Co-occurring Abbreviation)
Long Form:   palmitoylethanolamide
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer's Disease. AD, IL-16, ROS
2020 Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors. NAAA, OEA, PPAR-alpha, SAR
2020 Effect of Hataedock Treatment on Epidermal Structure Maintenance through Intervention in the Endocannabinoid System. AD, CB, CD1a, DFE, ECS, GPR55, GPX4, HTD, LASS2, p-ERK, p-JNK, p-mTOR
2020 Effect of intravenous, perioperative-administered lidocaine on serum levels of endocannabinoids and related N-acylethanolamines in children. 2-AG, AEA, i.v, LG, NAEs, NLG, OEA
2020 Fatty acid amide hydrolase inhibition in the central nervous system prevents and reverses morphine tolerance in male and female mice. CB2, FAAH, NAPE-PLD, PPAR-alpha
2020 First evidence on the role of palmitoylethanolamide in energy homeostasis in fish. FAS
2020 Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide). 2-AG, eCB, OEA
2020 Measuring the placebo effect in carpal tunnel syndrome. FSS, SSS, VAS
2020 Ocular Formulation Based on Palmitoylethanolamide-Loaded Nanostructured Lipid Carriers: Technological and Pharmacological Profile. HSH, HSH/US, NLC, TNF-alpha
10  2020 Palmitoylethanolamide counteracts hepatic metabolic inflexibility modulating mitochondrial function and efficiency in diet-induced obese mice. AMPK, HFD, PPAR
11  2020 The Effect of Orally Dosed Levagen+™ (palmitoylethanolamide) on Exercise Recovery in Healthy Males-A Double-Blind, Randomized, Placebo-Controlled Study. ---
12  2019 A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis. DASS, NRS, PSQI, PSS, WOMAC
13  2019 Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis. 2-AG, AEA, DAGs, EC, MCs, OEA, PLs
14  2019 Broad Lipidomic and Transcriptional Changes of Prophylactic PEA Administration in Adult Mice. LC-MRM, PPARalpha
15  2019 Clinical and in vitro evaluation of new anti-redness cosmetic products in subjects with winter xerosis and sensitive skin. AR, NAD, NAM, WVTR
16  2019 Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review. CENTRAL
17  2019 Cocaine-Induced Reinstatement of Cocaine Seeking Provokes Changes in the Endocannabinoid and N-Acylethanolamine Levels in Rat Brain Structures. 2-AG, AEA, NAEs, OEA
18  2019 Diurnal Profiles of N-Acylethanolamines in Goldfish Brain and Gastrointestinal Tract: Possible Role of Feeding. NAEs, OEA, SEA
19  2019 Effects of a new compound containing Palmitoylethanolamide and Baicalein in myocardial ischaemia/reperfusion injury in vivo. I/R
20  2019 Effects of the glial modulator palmitoylethanolamide on chronic pain intensity and brain function. NP
21  2019 Efficacy of a Combination of N-Palmitoylethanolamide, Beta-Caryophyllene, Carnosic Acid, and Myrrh Extract on Chronic Neuropathic Pain: A Preclinical Study. CCI, NP
22  2019 Endocannabinoid and N-acylethanolamide levels in rat brain and spinal cord following systemic dipyrone and paracetamol administration. 2-AG, OEA, PAG, RVM
23  2019 Endocannabinoid Metabolome Characterization of Milk from Guatemalan Women Living in the Western Highlands. AG, ARA, DHA, ECM, EPA
24  2019 Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma. AEA, EC, FAAH, NAEs, NAPE-PLD, OEA
25  2019 Formation of HETE-EAs and dihydroxy derivatives in mouse kidney tissue and analysis by high-performance liquid chromatography tandem mass spectrometry. 2-AG, AEA, DiHETE-EA, FAAH, MAGL, OEA
26  2019 Identification of Novel Predictive Biomarkers for Endometrial Malignancies: N-Acylethanolamines. AUC, CB1, EC, OEA, ROC
27  2019 Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses. 2-AG, AAV, AEA, DSE, FAAH, LTD, LTP, OEA
28  2019 Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa. 2-AG, ABA, AEA, AN, CB1R, eCB, OEA
29  2019 Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward. CPP, FOB, NAAA, OEA, PPARalpha
30  2019 Lower circulating endocannabinoid levels in children with autism spectrum disorder. 2-AG, AA, ASD, ECS, OEA, VABS-II
31  2019 Molecular Targets of Fatty Acid Ethanolamides in Asthma. NGF
32  2019 N-Palmitoylethanolamide Exerts Antidepressant-Like Effects in Rats: Involvement of PPARalpha Pathway in the Hippocampus. ACTH, CORT, CUMS, PPARalpha
33  2019 N-Palmitoylethanolamine Maintains Local Lipid Homeostasis to Relieve Sleep Deprivation-Induced Dry Eye Syndrome. PPAR-alpha
34  2019 N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion. NAAA, PEA-OXA, PEA-OXA, VaD
35  2019 New Insights of Uterine Leiomyoma Pathogenesis: Endocannabinoid System. AEA, CB1, FAAH, NAE, NAPE-PLD, OEA, TRPV1
36  2019 Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer. BPH, LUTS
37  2019 Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague-Dawley rats. AEA, CB1, i.p, MWD, OEA, OlGly, PPARalpha
38  2019 Opposite Effects of Neuroprotective Cannabinoids, Palmitoylethanolamide, and 2-Arachidonoylglycerol on Function and Morphology of Microglia. 2-AG, Abn-CBD, LPS, OHSC, PPAR
39  2019 Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer's Disease. MCI, SPECT
40  2019 Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial. CB1, CB2, CBD, ELISA, FD10, FD4, GPR119, GPR55, IFN-gamma, PKA, PKC, PPAR, TNF-alpha, TRPV1
41  2019 Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity. 2-AG, CB2, DAGL, SP, TRPV1
42  2019 Partial Reversal of Striatal Damage by Palmitoylethanolamide Administration Following Perinatal Asphyxia. GFAP, MAP-2, PA
43  2019 Prediction of preterm labour from a single blood test: The role of the endocannabinoid system in predicting preterm birth in high-risk women. AEA, NAEs, OEA, PTB, RTDI
44  2019 Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis. ---
45  2019 Role of cannabinoid receptor 1 and the peroxisome proliferator-activated receptor alpha in mediating anti-nociceptive effects of synthetic cannabinoids and a cannabinoid-like compound. CB1, MIA, OA, PPARalpha, PWT
46  2019 Role of palmitoylethanolamide (PEA) in depression: Translational evidence: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mo PPAR-alpha
47  2019 Sinerga may prevent recurrent respiratory infections in allergic children. RRI
48  2019 Stimulation of Peroxisome Proliferator-Activated Receptor-alpha by N-Palmitoylethanolamine Engages Allopregnanolone Biosynthesis to Modulate Emotional Behavior. PPAR
49  2019 Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors. ALI, FAAH, FAEs, LPS, NAAA, SAR
50  2019 The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice. DPN, STZ
51  2019 The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review. ---
52  2019 The role of transient receptor potential vanilloid receptor 1 and peroxisome proliferator-activated receptors-alpha in mediating the antinociceptive effects of palmitoylethanolamine in rats. CFA, PPARalpha
53  2019 Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets. ---
54  2019 Ultra-micronized palmitoylethanolamide rescues the cognitive decline-associated loss of neural plasticity in the neuropathic mouse entorhinal cortex-dentate gyrus pathway. 2-AG, LEC, SNI
55  2018 2-Pentadecyl-2-Oxazoline Reduces Neuroinflammatory Environment in the MPTP Model of Parkinson Disease. MPTP, PD, PEA-OXA
56  2018 Altered hair endocannabinoid levels in mothers with childhood maltreatment and their newborns. 1-AG, CM, EC, OEA, SEA
57  2018 An Analysis of Endocannabinoid Concentrations and Mood Following Singing and Exercise in Healthy Volunteers. AEA, eCBs, HR, OEA
58  2018 Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy. COX-2, eCB, eiC, FAAH, i.c, i.p, KA, MES, PTZ, TLE
59  2018 Bioactive lipids ALIAmides differentially modulate inflammatory responses of distinct subsets of primary human T lymphocytes. ALIAmides, DTEA, ETEA, FOXP3, OEA, SEA
60  2018 Co-Ultramicronized Palmitoylethanolamide/Luteolin Facilitates the Development of Differentiating and Undifferentiated Rat Oligodendrocyte Progenitor Cells. CNS, MBP, MS, OPCs, PDGF, SFM
61  2018 Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination. 2-AG, ABHD6, MS
62  2018 Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush. NAEs, PEA-OXA
63  2018 Effects of a Weight Loss Program on Metabolic Syndrome, Eating Disorders and Psychological Outcomes: Mediation by Endocannabinoids? ED, MS, QOL
64  2018 Effects of Add-On Ultramicronized N-Palmitol Ethanol Amide in Patients Suffering of Migraine With Aura: A Pilot Study. MA
65  2018 Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety. EPM, FAAH, i.p, OEA, PPAR-alpha, TMT
66  2018 Endocannabinoid Anandamide Mediates the Effect of Skeletal Muscle Sphingomyelins on Human Energy Expenditure. 2-AG, AEA, OEA, SLEEP
67  2018 Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia. 2-AG, 2-OG, AEA, eCB, EIH, OEA
68  2018 Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism. 2-AG, AEA, eCB, HS, OEA, PBMCs, SLE
69  2018 Experimental ischemia/reperfusion model impairs endocannabinoid signaling and Na+/K+ ATPase expression and activity in kidney proximal tubule cells. ECS, IR, MAGL, OEA
70  2018 Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases. AEA, HPA, IBD, IBS, NAE, OEA, SCFAs
71  2018 HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia. EGC, PPAR
72  2018 Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215. ALI, LPS, NAAA, TPA
73  2018 Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery. NLCs
74  2018 Intrathecal morphine administration reduces postoperative pain and peripheral endocannabinoid levels in total knee arthroplasty patients: a randomized clinical trial. 2-AG, AEA, OEA, TKA
75  2018 Limited Access to a High Fat Diet Alters Endocannabinoid Tone in Female Rats. 2-AG, AEA, BED, CB1, CTRL, HFD, HR, LR, OEA
76  2018 N-Palmitoyl Ethanol Amide Pharmacological Treatment in Patients With Nonsurgical Lumbar Radiculopathy. um-PEA
77  2018 N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice. MPTP, PD
78  2018 Nonsurgical lumbar radiculopathies treated with ultramicronized palmitoylethanolamide (umPEA): A series of 100 cases. um-PEA, umPEA
79  2018 Oleoylethanolamide and Palmitoylethanolamide Protect Cultured Cortical Neurons Against Hypoxia. HI, KO, OEA, PPARalpha, TRPV
80  2018 Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect. ---
81  2018 Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats. SMA, TGF
82  2018 Palmitoylethanolamide Ameliorates Hippocampal Damage and Behavioral Dysfunction After Perinatal Asphyxia in the Immature Rat Brain. EPM, OF, PA, PA
83  2018 Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial. ABC-C, CI
84  2018 Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial. DSM-5, HAM-D, MDD
85  2018 Palmitoylethanolamide attenuates cocaine-induced behavioral sensitization and conditioned place preference in mice. BS, CPP, NAEs
86  2018 Palmitoylethanolamide Blunts Amyloid-beta42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures. ---
87  2018 Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms. ASD, PPAR
88  2018 Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence. AD
89  2018 Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia. AI, OEA, PPARalpha
90  2018 Plasma N-acylethanolamine and endocannabinoid levels in burning mouth syndrome: Potential role in disease pathogenesis. 2-AG, AEA, BMS, eCB, NAE, OEA
91  2018 Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism. AEA, BMI, NW, OB, OEA, OW
92  2018 Prophylactic Palmitoylethanolamide Prolongs Survival and Decreases Detrimental Inflammation in Aged Mice With Bacterial Meningitis. ---
93  2018 Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress Disorder. 2-AG, 2-OG, AEA, eCBs, MHR, OEA, PTSD
94  2018 Satiety Factors Oleoylethanolamide, Stearoylethanolamide, and Palmitoylethanolamide in Mother's Milk Are Strongly Associated with Infant Weight at Four Months of Age-Data from the Odense Child Cohort. OEA, SEA, WAZ
95  2018 Secretion, isotopic labeling and deglycosylation of N-acylethanolamine acid amidase for biophysical studies. NAAA, Ntn
96  2018 The Relationship of Endocannabinoidome Lipid Mediators With Pain and Psychological Stress in Women With Fibromyalgia: A Case-Control Study. 2-AG, AEA, FM, OEA, SEA
97  2018 The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents. AEA, eCB, FAAH, OEA
98  2018 Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception. ---
99  2018 Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects. AD, MRI/MRS, RT-PCR, um-PEA
100  2017 2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation. CAR, NAEs, PEA-OXA